The global positive air pressure devices market is projected to witness substantial growth over the forecast period, according to a new market research report by FMI. The report reveals that the market, which reached a valuation of US$ 2.3 Billion in 2021, is poised to achieve a valuation of US$ 2.5 Billion by the end of 2022. Furthermore, it is expected to surpass a market valuation of US$ 4.7 Billion by 2032, reflecting a compound annual growth rate (CAGR) of 6.4% during the period 2022-2032.
Positive air pressure devices, including continuous positive airways pressure (CPAP) devices and mechanical ventilators, are witnessing increased adoption globally due to their efficacy in treating medical conditions such as sleep apnea and respiratory failures. The continuous positive airways pressure devices segment dominated the market in 2021 with a share of about 71.4%, a trend expected to continue during the forecast period.
Get Sample Copy of Latest Reports: https://www.futuremarketinsights.com/reports/sample/rep-gb-5623
Mechanical ventilators play a crucial role in assisting patients with breathing difficulties, ensuring sufficient oxygen supply and carbon dioxide expulsion. With advancements in positive airway pressure systems and enhancements in the battery life of transportation and portable devices, the adoption of mechanical ventilators is expected to rise steadily.
“We are witnessing a significant surge in the adoption of positive air pressure devices globally, driven by factors such as technological advancements and the rising prevalence of sleep apnea and respiratory disorders,” said FMI. “As the demand for effective respiratory treatments continues to grow, we anticipate sustained growth in the positive air pressure devices market in the coming years.”
Key findings from the report include:
- The global positive air pressure devices market is expected to achieve a valuation of US$ 2.5 Billion by the end of 2022.
- The market is projected to witness a CAGR of 6.4% during the forecast period 2022-2032, surpassing a valuation of US$ 4.7 Billion by 2032.
- Continuous positive airways pressure (CPAP) devices are anticipated to maintain their dominance in the market throughout the forecast period.
- Technological advancements and improvements in battery life are driving the adoption of mechanical ventilators.
Click Here to Request Methodology: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-5623
Key Trends Driving the Positive Air Pressure Devices Market:
Rising Prevalence of Sleep Disorders and Respiratory Diseases:
- Increasing cases of COPD and Obstructive Sleep Apnea (OSA) are fueling market growth.
- Positive airway pressure therapy has shown effectiveness in treating these conditions, leading to higher demand for PAP devices.
Growing Geriatric Population:
- OSA prevalence is higher in older adults, and PAP therapy can improve their independence and reduce healthcare costs.
Technological Advancements:
- Introduction of new features like automatic pressure adjustment (APAP) and Bi-level Positive Airway Pressure (BiPAP) caters to diverse patient needs and drives market demand.
Improved Treatment Outcomes:
- Studies show positive airway pressure therapy reduces hospitalizations for COPD and improves quality of life for OSA patients. This fosters market growth.
Key Companies Profiled:
- 3B Medical, Inc
- Hamilton Medical AG
- BMC Medical Co. Ltd
- Breas Medical AB
- Compumedics Limited
- Drive DeVilbiss Healthcare
- Elmaslar Group
- Fisher & Paykel Healthcare Corporation Limited
- Hebei Topson Medical Technology Co., Ltd.
- Kare Medical and Analytical Devices Ltd. Co
- Koninklijke Philips N.V
- Lowenstein Medical Technology GmbH.
- Narang Medical Limited.
- Somnetics International, Inc.
- Draegerwerk AG & Co. KGaA
- Apex Medical Corporation
- ResMed Inc.
Request Purchase Now: https://www.futuremarketinsights.com/checkout/5623
Key Market Segments Covered in Positive Air Pressure Devices Market Research:
By Product:
- Continuous Positive Airways Pressure Devices (CPAP)
- Bi-level Positive Airway Pressure (BiPAP)/ Variable Positive Airway Pressure (VPAP)
- Automatic Positive Airway Pressure Devices (APAP)
By Application:
- Obstructive sleep apnea
- Respiratory failures
- Others
By End User:
- Hospitals
- Clinics
- Sleep Centers
- Home care settings
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
